The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19

Affiliations

¹ Department of Pharmacology, All India Institute of Medical Sciences Bhopal, Bhopal 462020, Madhya Pradesh, India. Electronic address: balakrishnan.pharm@aiimsbhopal.edu.in.
² Department of Pharmacology, All India Institute of Medical Sciences Bhopal, Bhopal 462020, Madhya Pradesh, India. Electronic address: shubham.pharm@aiimsbhopal.edu.in.
³ Department of Pharmacology, All India Institute of Medical Sciences Bhopal, Bhopal 462020, Madhya Pradesh, India. Electronic address: avik.jrpharma18@aiimsbhopal.edu.in.
⁴ Department of Pharmacology, All India Institute of Medical Sciences Bhopal, Bhopal 462020, Madhya Pradesh, India. Electronic address: dr.swatisharma@outlook.com.

Comment

Balakrishnan Sadasivam et al. Int J Infect Dis. 2020 Nov.

. 2020 Nov:100:25-26.

doi: 10.1016/j.ijid.2020.08.058. Epub 2020 Aug 27.

¹ Department of Pharmacology, All India Institute of Medical Sciences Bhopal, Bhopal 462020, Madhya Pradesh, India. Electronic address: balakrishnan.pharm@aiimsbhopal.edu.in.
² Department of Pharmacology, All India Institute of Medical Sciences Bhopal, Bhopal 462020, Madhya Pradesh, India. Electronic address: shubham.pharm@aiimsbhopal.edu.in.
³ Department of Pharmacology, All India Institute of Medical Sciences Bhopal, Bhopal 462020, Madhya Pradesh, India. Electronic address: avik.jrpharma18@aiimsbhopal.edu.in.
⁴ Department of Pharmacology, All India Institute of Medical Sciences Bhopal, Bhopal 462020, Madhya Pradesh, India. Electronic address: dr.swatisharma@outlook.com.

No abstract available

Comment on

Effectiveness of hydroxychloroquine in COVID-19 disease: A done and dusted deal?
d'Arminio Monforte A, Tavelli A, Bai F, Marchetti G, Cozzi-Lepri A. d'Arminio Monforte A, et al. Int J Infect Dis. 2020 Oct;99:75-76. doi: 10.1016/j.ijid.2020.07.056. Epub 2020 Jul 29. Int J Infect Dis. 2020. PMID: 32738491 Free PMC article. No abstract available.

1. Centers for Disease Control and Prevention . 2020. Duration of isolation and precautions for adults with COVID-19.https://www.cdc.gov/coronavirus/2019-ncov/hcp/duration-isolation.html [Accessed 3 August 2020]
1. d’Arminio Monforte A., Tavelli A., Bai F., Marchetti G., Cozzi-Lepri A. Effectiveness of hydroxychloroquine in COVID-19 disease: a done and dusted situation? Int J Infect Dis. 2020 doi: 10.1016/j.ijid.2020.07.056. - DOI - PMC - PubMed
1. Inserm . 2020. Discovery: stopping inclusions in two treatment groups.https://presse.inserm.fr/en/discovery-stopping-inclusions-in-two-treatme...
1. Lê M.P., Peiffer-Smadja N., Guedj J., Néant N., Mentré F., Florence Ader Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial. J Antimicrob Chemother. 2020;75:2376–2380. doi: 10.1093/jac/dkaa191. - DOI - PMC - PubMed
1. Liu J., Cao R., Xu M., Wang X., Zhang H., Hu H. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. 2020;6:16. doi: 10.1038/s41421-020-0156-0. - DOI - PMC - PubMed